Aclasta 5mg/100ml Solution for Infusion
Product details
Registration number: SIN13192P
Classification: Prescription Only
Active ingredients: zoledronic acid
Strength: 5mg
Dosage form: INFUSION, SOLUTION
Route: INTRAVENOUS
Registrant: SANDOZ SINGAPORE PTE. LTD.
ATC code: M05BA08
HSA approval date: 30 March 2006
Manufacturer(s): Fresenius Kabi Austria GmbH
Manufacturing country/countries: AUSTRIA
What are the HSA registration number and classification for Aclasta 5mg/100ml Solution for Infusion?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13192P
Classification: Prescription Only
What active ingredients and strength are recorded for Aclasta 5mg/100ml Solution for Infusion?
According to the HSA dataset updated 7 August 2026:
Active ingredients: zoledronic acid
Strength: 5mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Aclasta 5mg/100ml Solution for Infusion?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for Aclasta 5mg/100ml Solution for Infusion?
According to the HSA dataset updated 7 August 2026:
Registrant: SANDOZ SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Aclasta 5mg/100ml Solution for Infusion?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Fresenius Kabi Austria GmbH
Manufacturing country/countries: AUSTRIA
Where can I look up Aclasta 5mg/100ml Solution for Infusion in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13192P or the exact product name Aclasta 5mg/100ml Solution for Infusion. The general register link does not preselect this product.
What are the source dates for this Aclasta 5mg/100ml Solution for Infusion record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Aclasta 5mg/100ml Solution for Infusion record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13192P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)